{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:28:40Z","timestamp":1761488920204},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2011.12.061","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T17:38:37Z","timestamp":1337189917000},"page":"B73-B77","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S2","title":["The use of vaccine antigen characterization, for example by MATS, to guide the introduction of meningococcus B vaccines"],"prefix":"10.1016","volume":"30","author":[{"given":"Ulrich","family":"Vogel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Stefanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Claus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (16)","key":"10.1016\/j.vaccine.2011.12.061_bib0005","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMra0906357","article-title":"Advances in the development of vaccines against Neisseria meningitidis","volume":"362","author":"Tan","year":"2010","journal-title":"N Engl J Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.12.061_bib0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrmicro1872","article-title":"Microbial diversity and the genetic nature of microbial species","volume":"6","author":"Achtman","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.061_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2958.2003.03819.x","article-title":"Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci","volume":"51","author":"Claus","year":"2004","journal-title":"Mol Microbiol"},{"issue":"September (2)","key":"10.1016\/j.vaccine.2011.12.061_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s004300050018","article-title":"Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis serogroup B are prerequisites for virulence of meningococci in the infant rat","volume":"185","author":"Vogel","year":"1996","journal-title":"Med Microbiol Immunol"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2011.12.061_bib0025","first-page":"20","article-title":"Vaccine development against Neisseria meningitidis","volume":"4","author":"Vogel","year":"2010","journal-title":"Microb Biotechnol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.061_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-6976.2006.00057.x","article-title":"Molecular typing of meningococci: recommendations for target choice and nomenclature","volume":"31","author":"Jolley","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2011.12.061_bib0035","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection \u2013 serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2011.12.061_bib0040","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.vaccine.2005.01.058","article-title":"The concept of tailor-made, protein-based, outer membrane vesicle vaccines against meningococcal disease","volume":"23","author":"Holst","year":"2005","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.12.061_bib0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(11)70027-5","article-title":"From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak","volume":"11","author":"Caron","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2011.12.061_bib0050","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (37)","key":"10.1016\/j.vaccine.2011.12.061_bib0055","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.061_bib0060","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2010.11.064","article-title":"Influence of sequence variability on bactericidal activity sera induced by factor H binding protein variant 1.1","volume":"29","author":"Brunelli","year":"2011","journal-title":"Vaccine"},{"issue":"November (45)","key":"10.1016\/j.vaccine.2011.12.061_bib0065","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2011.12.061_bib0070","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.12.061_bib0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/367899","article-title":"Outbreak of meningococcal disease caused by PorA-deficient meningococci","volume":"187","author":"van der Ende","year":"2003","journal-title":"J Infect Dis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.12.061_bib0080","first-page":"657","article-title":"Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003","volume":"135","author":"Schrauder","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.061_bib0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1574-6976.2006.00059.x","article-title":"Diagnosis and management of meningococcal disease: the need for centralized care","volume":"31","author":"Nadel","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.12.061_bib0090","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1128\/JCM.43.12.6007-6014.2005","article-title":"Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters","volume":"43","author":"Birtles","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.12.061_bib0095","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/AAC.47.11.3430-3434.2003","article-title":"Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections","volume":"47","author":"Vazquez","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.061_bib0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/JCM.43.1.144-149.2005","article-title":"Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis","volume":"43","author":"Taha","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"May (7)","key":"10.1016\/j.vaccine.2011.12.061_bib0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijmm.2010.04.017","article-title":"Molecular epidemiology of meningococci: application of DNA sequence typing","volume":"300","author":"Vogel","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.061_bib0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2011.12.061_bib0115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2105-7-314","article-title":"AgdbNet \u2013 antigen sequence database software for bacterial typing","volume":"7","author":"Jolley","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.12.061_bib0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.061_bib0125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1574-6976.2006.00052.x","article-title":"Lessons from meningococcal carriage studies","volume":"31","author":"Caugant","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.12.061_bib0130","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/428590","article-title":"Genetic analysis of meningococci carried by children and young adults","volume":"191","author":"Claus","year":"2005","journal-title":"J Infect Dis"},{"issue":"May (4)","key":"10.1016\/j.vaccine.2011.12.061_bib0135","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2958.2009.06710.x","article-title":"Expression of the meningococcal adhesin NadA is controlled by a transcriptional regulator of the MarR family","volume":"72","author":"Schielke","year":"2009","journal-title":"Mol Microbiol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.12.061_bib0140","doi-asserted-by":"crossref","first-page":"e1000710","DOI":"10.1371\/journal.ppat.1000710","article-title":"A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements","volume":"5","author":"Metruccio","year":"2009","journal-title":"PLoS Pathog"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.12.061_bib0145","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.vaccine.2008.12.052","article-title":"Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease","volume":"27","author":"Jacobsson","year":"2009","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.12.061_bib0150","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/AAC.00412-07","article-title":"Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis","volume":"51","author":"Taha","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.12.061_bib0155","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3201\/eid1211.060682","article-title":"Spatiotemporal analysis of invasive meningococcal disease, Germany","volume":"12","author":"Elias","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.061_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1574-6976.2006.00056.x","article-title":"Multilocus sequence typing for global surveillance of meningococcal disease","volume":"31","author":"Brehony","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.061_bib0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.vaccine.2011.11.050","article-title":"Capsule null locus meningococci: typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine","volume":"30","author":"Claus","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T16:38:23Z","timestamp":1713976703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11019967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":33,"alternative-id":["S0264410X11019967"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}